These smaller syringes have finer graduation marks, making it easier to measure very small doses accurately
Patients in Sandy Springs and Atlanta have joined lawsuits after experiencing long-term injuries that required hospitalization, ongoing treatment, and significant medical expenses
The primary endpoint in DEVOTE was time from randomization to the first occurrence of a 3 component major adverse cardiovascular event (MACE): cardiovascular death, non fatal myocardial infarction, or non fatal stroke
FDA-Approved GLP-1 Drugs Expected Annual Health Plan Costs for a 250-Life Employer Group Source:[10] Berkley Accident and Health Internal Data While it remains to be seen exactly how insurers will manage these rising costs, we estimate that an employer with 250 covered employees will spend between $60,000-$112,000 on GLP-1s alone in 2025
Have you started a GLP-1 medication recently